Efisol

Medicinal product

(Invented) name

Efisol

Active substance (s)

Dekvalinio chloridas/Askorbo rūgštis

Strength

0,25 mg/30 mg

Pharmaceutical form

suslėgtosios pastilės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R02AA02, Dequalinium

Marketing authorisation holder

Actavis Group PTC ehf., Islandija

Date of authorisation

2001-04-11

Date of renewal

2012-02-28

Documents

2818_1 Efisol pastiles RPP 180529.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Pastilėje yra	1 vnt.
Dekvalinio chloridas	0,25 mg
Askorbo rūgštis	30 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
4920	10242	1010242	lizdinė plokštelė	N20		Nereceptinis	LT/1/01/2818/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-03-31	Išregistruotas
2012-02-28	Perregistruotas
2001-04-11	Registruotas